Shukra Pharma.
BSE: SHUKRAPHAR · Pharmaceuticals
Snapshot
Unlock Shukra Pharma.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Shukra Pharmaceuticals Ltd. is an Ahmedabad-based company engaged in the manufacturing and marketing of a diverse range of pharmaceutical products. Its extensive portfolio encompasses various therapeutic categories, including antibiotics, anti-virals, analgesics, and corticosteroids, serving both domestic and international markets.
Business Model
The company generates revenue through the production and sale of a broad spectrum of pharmaceutical formulations. It operates as a manufacturer and marketer, distributing its medicinal products across diverse therapeutic segments.
- Incorporation Date:March 4, 1993
Growth Outlook
Growth is expected to be driven by the expansion of its wide-ranging pharmaceutical product portfolio and the continued penetration of both domestic and international markets.
Key Risks
- Regulatory Compliance. The company faces stringent regulatory oversight from health authorities, where non-compliance could lead to product recalls or manufacturing suspensions.
- Market Competition. The pharmaceutical sector is highly competitive, with numerous players exerting pressure on pricing and profit margins.
- Raw Material Price Volatility. Fluctuations in the cost of Active Pharmaceutical Ingredients (APIs) and other raw materials can significantly impact production costs and profitability.
- Geopolitical and Export Risks. Operating in international markets exposes the company to currency fluctuations, trade barriers, and varying regulatory standards across different countries.
Price
Start your research today
Unlock AI insights, financials, peers and live data on Shukra Pharma. and 5,000+ companies — free.
Peers · Pharmaceuticals
| Company | Mkt Cap (Cr) | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Shukra Pharma.SHUKRAPHAR | — | — | — | — | 51.0% | — | — | +56.1% |
Sun Pharmaceutical Industries Ltd.SUNPHARMA | 4,23,002 | 40.80 | 23.47 | 11.2% | 33.7% | 15.3% | 20.1% | +14.6% |
Divi's Laboratories Ltd.DIVISLAB | 1,60,263 | 75.62 | 49.16 | 12.8% | 37.4% | 16.7% | 21.2% | +7.1% |
Torrent Pharmaceuticals Ltd.TORNTPHARM | 1,43,993 | 78.03 | 40.87 | 21.4% | 31.9% | 27.4% | 19.5% | +44.2% |
Lupin Ltd.LUPIN | 1,06,687 | 21.42 | 12.56 | 23.1% | 33.1% | 28.9% | 33.8% | +29.6% |
Dr. Reddy's Laboratories Ltd.DRREDDY | 1,04,598 | 24.29 | 13.66 | 3.2% | 23.2% | 12.0% | 15.3% | -2.8% |
As of Mar 2026
Financials
Shukra Pharma.
BSE: SHUKRAPHAR · Pharmaceuticals
Snapshot
Unlock Shukra Pharma.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Shukra Pharmaceuticals Ltd. is an Ahmedabad-based company engaged in the manufacturing and marketing of a diverse range of pharmaceutical products. Its extensive portfolio encompasses various therapeutic categories, including antibiotics, anti-virals, analgesics, and corticosteroids, serving both domestic and international markets.
Business Model
The company generates revenue through the production and sale of a broad spectrum of pharmaceutical formulations. It operates as a manufacturer and marketer, distributing its medicinal products across diverse therapeutic segments.
- Incorporation Date:March 4, 1993
Growth Outlook
Growth is expected to be driven by the expansion of its wide-ranging pharmaceutical product portfolio and the continued penetration of both domestic and international markets.
Key Risks
- Regulatory Compliance. The company faces stringent regulatory oversight from health authorities, where non-compliance could lead to product recalls or manufacturing suspensions.
- Market Competition. The pharmaceutical sector is highly competitive, with numerous players exerting pressure on pricing and profit margins.
- Raw Material Price Volatility. Fluctuations in the cost of Active Pharmaceutical Ingredients (APIs) and other raw materials can significantly impact production costs and profitability.
- Geopolitical and Export Risks. Operating in international markets exposes the company to currency fluctuations, trade barriers, and varying regulatory standards across different countries.
Price
Loading…
Start your research today
Unlock AI insights, financials, peers and live data on Shukra Pharma. and 5,000+ companies — free.
Peers · Pharmaceuticals
As of Mar 2026